| The Polycomb group protein EZH2 directly controls DNA methylation E Viré, C Brenner, R Deplus, L Blanchon, M Fraga, C Didelot, L Morey, ... Nature 439 (7078), 871-874, 2006 | 2573 | 2006 |
| Mechanisms of cytochrome c release from mitochondria C Garrido, L Galluzzi, M Brunet, PE Puig, C Didelot, G Kroemer Cell Death & Differentiation 13 (9), 1423-1433, 2006 | 1565 | 2006 |
| Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties C Garrido, M Brunet, C Didelot, Y Zermati, E Schmitt, G Kroemer Cell cycle 5 (22), 2592-2601, 2006 | 884 | 2006 |
| Myc represses transcription through recruitment of DNA methyltransferase corepressor C Brenner, R Deplus, C Didelot, A Loriot, E Viré, C De Smet, A Gutierrez, ... The EMBO journal 24 (2), 336-346, 2005 | 578 | 2005 |
| Apoptosis versus cell differentiation: role of heat shock proteins HSP90, HSP70 and HSP27 D Lanneau, A de Thonel, S Maurel, C Didelot, C Garrido Prion 1 (1), 53-60, 2007 | 307 | 2007 |
| NF-κB modulation and ionizing radiation: mechanisms and future directions for cancer treatment N Magné, RA Toillon, V Bottero, C Didelot, P Van Houtte, JP Gérard, ... Cancer letters 231 (2), 158-168, 2006 | 237 | 2006 |
| Heat shock proteins: endogenous modulators of apoptotic cell death C Didelot, E Schmitt, M Brunet, L Maingret, A Parcellier, C Garrido Molecular chaperones in health and disease, 171-198, 2006 | 216 | 2006 |
| Anti-cancer therapeutic approaches based on intracellular and extracellular heat shock proteins C Didelot, D Lanneau, M Brunet, AL Joly, AD Thonel, G Chiosis, ... Current medicinal chemistry 14 (27), 2839-2847, 2007 | 176 | 2007 |
| Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination M Grapin, C Richard, E Limagne, R Boidot, V Morgand, A Bertaut, ... Journal for immunotherapy of cancer 7, 1-12, 2019 | 165 | 2019 |
| HSP27 favors ubiquitination and proteasomal degradation of p27Kip1 and helps S‐phase re‐entry in stressed cells A Parcellier, M Brunet, E Schmitt, E Col, C Didelot, A Hammann, ... The FASEB journal 20 (8), 1179-1181, 2006 | 153 | 2006 |
| Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status JF Mirjolet, M Barberi-Heyob, C Didelot, JP Peyrat, J Abecassis, R Millon, ... British journal of cancer 83 (10), 1380-1386, 2000 | 116 | 2000 |
| The radiosensitization effect of titanate nanotubes as a new tool in radiation therapy for glioblastoma: a proof-of-concept C Mirjolet, AL Papa, G Créhange, O Raguin, C Seignez, C Paul, G Truc, ... Radiotherapy and Oncology 108 (1), 136-142, 2013 | 115 | 2013 |
| The 6th R of radiobiology: reactivation of anti-tumor immune response J Boustani, M Grapin, PA Laurent, L Apetoh, C Mirjolet Cancers 11 (6), 860, 2019 | 111 | 2019 |
| Challenges in glioblastoma research: focus on the tumor microenvironment A Bikfalvi, CA da Costa, T Avril, JV Barnier, L Bauchet, L Brisson, ... Trends in cancer 9 (1), 9-27, 2023 | 86 | 2023 |
| Interaction of heat-shock protein 90β isoform (HSP90β) with cellular inhibitor of apoptosis 1 (c-IAP1) is required for cell differentiation C Didelot, D Lanneau, M Brunet, A Bouchot, J Cartier, A Jacquel, ... Cell Death & Differentiation 15 (5), 859-866, 2008 | 67 | 2008 |
| Clinical impact of margin reduction on late toxicity and short-term biochemical control for patients treated with daily on-line image guided IMRT for prostate cancer G Crehange, C Mirjolet, M Gauthier, E Martin, G Truc, ... Radiotherapy and Oncology 103 (2), 244-246, 2012 | 66 | 2012 |
| NOX2-dependent ATM kinase activation dictates pro-inflammatory macrophage phenotype and improves effectiveness to radiation therapy Q Wu, A Allouch, A Paoletti, C Leteur, C Mirjolet, I Martins, L Voisin, F Law, ... Cell Death & Differentiation 24 (9), 1632-1644, 2017 | 62 | 2017 |
| Polydopamine modified superparamagnetic iron oxide nanoparticles as multifunctional nanocarrier for targeted prostate cancer treatment N Singh, F Sallem, C Mirjolet, T Nury, SK Sahoo, N Millot, R Kumar Nanomaterials 9 (2), 138, 2019 | 51 | 2019 |
| Constitutive NF-κB activity influences basal apoptosis and radiosensitivity of head-and-neck carcinoma cell lines C Didelot, M Barberi-Heyob, A Bianchi, P Becuwe, JF Mirjolet, M Dauca, ... International Journal of Radiation Oncology* Biology* Physics 51 (5), 1354-1360, 2001 | 49 | 2001 |
| G1/S but not G0/G1 cell fraction is related to 5‐fluorouracil cytotoxicity JF Mirjolet, C Didelot, M Barberi‐Heyob, JL Merlin Cytometry: The Journal of the International Society for Analytical Cytology …, 2002 | 41 | 2002 |
